• S2:E2 – SGLT-2 Inhibitors Morning Commute: The Heart Failure Connection

  • Mar 30 2021
  • Length: 24 mins
  • Podcast
S2:E2 – SGLT-2 Inhibitors Morning Commute: The Heart Failure Connection By cover art

S2:E2 – SGLT-2 Inhibitors Morning Commute: The Heart Failure Connection

Listen for free

View show details

  • Summary

  • Visit http://morningcommutepodcast.com/SGLT2inhibitors5 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode Dr. James Januzzi and Dr. Silvio Inzucchi discuss how sodium-glucose cotransporter 2 (SGLT-2) inhibitors evolved from treatments for type 2 diabetes mellitus (T2DM) to key treatments for patients with heart failure. Drs. Januzzi and Inzucchi look at the pivotal trials that thrust these treatments into the heart failure treatment limelight.
    Show more Show less
Show more Show less

What listeners say about S2:E2 – SGLT-2 Inhibitors Morning Commute: The Heart Failure Connection

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available